RankAlpha logo
Back to Rankings

BMY

Bristol-Myers SquibbC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
BMY vs peer average
42/100
BMY vs. peer average (C vs. B)
Grade spread
A 1 · B 5 · C 2 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

JNJ is the first available peer comparator.

Large diversified pharma with broad consumer/medtech exposure; defensive revenue mix compared with BMY's oncology focus.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerJNJJohnson Johnson
BMY
Bristol-Myers Squibb
JNJ
Johnson Johnson
Grade
C
B
Momentum
54
51
Value
68
62
Sentiment
47
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs JNJ

BMY / JNJ
Grade Position
Below peers
BMY vs. peer average (C vs. B)
42/100
Momentum
54
BMY
Value
68
BMY
Sentiment
47
JNJ

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BMY
1
JNJ
JNJ
B
80/100
-1
2
MRK
MRK
C
60/100
Even
3
PFE
PFE
B
80/100
-1
4
VRTX
Vertex Pharmaceuticals Inc Common
B
80/100
-1
5
DHR
Danaher Corp Common
D
40/100
+1
JNJ is the first peer returned for this comparison set.